End-to-end biopharmaceutical services

Siemens Healthcare Laboratory

End-to-end diagnostic solutions for biopharma partner therapy development programs

Siemens Healthcare Laboratory (SHL), LLC offers end-to-end diagnostic solutions for our biopharma partner therapy development programs. Our services may begin with biomarker discovery, leading to prototype development, use in clinical trials, followed by optional development and commercialization of In Vitro Diagnostic (IVD) assays.

  • Our rigorous, stepwise biomarker-development process supports development of high-quality biomarker assays for early- to late-stage clinical trials testing.
  • Assay prototypes of these biomarkers can be developed on our proprietary technology clinical laboratory platforms and validated for fit for purpose uses.
  • Our CAP-accredited, CLIA-licensed laboratory offers high-quality testing services to support your clinical trial needs and beyond.

To find out more about our end-to-end biopharmaceutical services, and our CLIA lab, please visit our US site: